Saunderson P - Search Results

1

Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.

Cambau E, Saunderson P, Matsuoka M, Cole ST, Kai M, Suffys P, Rosa PS, Williams D, Gupta UD, Lavania M, Cardona-Castro N, Miyamoto Y, Hagge D, Srikantam A, Hongseng W, Indropo A, Vissa V, Johnson RC, Cauchoix B, Pannikar VK, Cooreman EAWD, Pemmaraju VRR, Gillini L; WHO surveillance network of antimicrobial resistance in leprosy. Cambau E, et al. Among authors: saunderson p. Clin Microbiol Infect. 2018 Dec;24(12):1305-1310. doi: 10.1016/j.cmi.2018.02.022. Epub 2018 Mar 1. Clin Microbiol Infect. 2018. PMID: 29496597 Free PMC article.

2

The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.

Matsuoka M, Budiawan T, Aye KS, Kyaw K, Tan EV, Cruz ED, Gelber R, Saunderson P, Balagon V, Pannikar V. Matsuoka M, et al. Among authors: saunderson p. Lepr Rev. 2007 Dec;78(4):343-52. Lepr Rev. 2007. PMID: 18309708

3

A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries.

Matsuoka M, Aye KS, Kyaw K, Tan EV, Balagon MV, Saunderson P, Gelber R, Makino M, Nakajima C, Suzuki Y. Matsuoka M, et al. Among authors: saunderson p. J Med Microbiol. 2008 Oct;57(Pt 10):1213-1219. doi: 10.1099/jmm.0.2008/002600-0. J Med Microbiol. 2008. PMID: 18809547

4

Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.

Balagon MF, Cellona RV, Cruz Ed, Burgos JA, Abalos RM, Walsh GP, Saunderson PR, Walsh DS. Balagon MF, et al. Among authors: saunderson pr. Am J Trop Med Hyg. 2009 Nov;81(5):895-9. doi: 10.4269/ajtmh.2009.09-0189. Am J Trop Med Hyg. 2009. PMID: 19861628

5

A continuation: study and characterisation of Mycobacterium leprae short tandem repeat genotypes and transmission of leprosy in Cebu, Philippines.

Sakamuri RM, Harrison J, Gelber R, Saunderson P, Brennan PJ, Balagon M, Vissa V. Sakamuri RM, et al. Among authors: saunderson p. Lepr Rev. 2009 Sep;80(3):272-9. Lepr Rev. 2009. PMID: 19961100

6

The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.

Balagon MF, Cellona RV, Abalos RM, Gelber RH, Saunderson PR. Balagon MF, et al. Lepr Rev. 2010 Mar;81(1):27-33. Lepr Rev. 2010. PMID: 20496567 Clinical Trial.

7

Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

Spencer JS, Kim HJ, Wheat WH, Chatterjee D, Balagon MV, Cellona RV, Tan EV, Gelber R, Saunderson P, Duthie MS, Reece ST, Burman W, Belknap R, Mac Kenzie WR, Geluk A, Oskam L, Dockrell HM, Brennan PJ; IDEAL Consortium. Spencer JS, et al. Among authors: saunderson p. Clin Vaccine Immunol. 2011 Feb;18(2):260-7. doi: 10.1128/CVI.00472-10. Epub 2010 Dec 22. Clin Vaccine Immunol. 2011. PMID: 21177913 Free PMC article.

8

Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.

Maghanoy A, Mallari I, Balagon M, Saunderson P. Maghanoy A, et al. Among authors: saunderson p. Lepr Rev. 2011 Mar;82(1):65-9. Lepr Rev. 2011. PMID: 21644473

9

Report on the sixth meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held in Beijing, China on 23-25 August 2010.

Dockrell HM, Geluk A, Brennan P, Saunderson PR, Oskam L, Lockwood DN, Xiaoman W, Richardus JH. Dockrell HM, et al. Among authors: saunderson pr. Lepr Rev. 2011 Mar;82(1):80-5. Lepr Rev. 2011. PMID: 21644477 No abstract available.

10

Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.

Balagon M, Saunderson PR, Gelber RH. Balagon M, et al. Lepr Rev. 2011 Sep;82(3):213-21. Lepr Rev. 2011. PMID: 22125929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page